Oncology Drug Production in Sub-Saharan Africa: The Challenge and Opportunity, with Evidence from India

Mackintosh, Maureen; Chaudhuri, Sudip; Mohamed, Nazeem; Wangwe, Samuel; Ngoma, Twalib and Manduku, Veronica (2024). Oncology Drug Production in Sub-Saharan Africa: The Challenge and Opportunity, with Evidence from India. In: Banda, Geoffrey; Mackintosh, Maureen; Njeru, Mercy; Srinivas, Smita and Makene, Fortunata Sangora eds. Cancer Care in Pandemic Times: Building inclusive local health security in Africa and India. International Political Economy Series. Switzerland: Palgrave Macmillan, pp. 163–188.

DOI: https://doi.org/10.1007/978-3-031-44123-3_8

Abstract

This chapter focuses on the scope for local production in East Africa of essential oncology medication, drawing on evidence of local clinical need; on Indian data on markets for generic oncology medication; and on industrial and regulatory experience. Import-dependence in oncology is almost complete across Sub-Saharan Africa, while India is a key exporter. The chapter documents competition failures in generic oncology markets and demonstrates the huge affordability impact of effective procurement of these medicines within India. Challenges for local oncology manufacturing are identified. The chapter argues that active health-industrial research linkages can build a local African oncology industry.

Viewing alternatives

Metrics

Item Actions

Export

You can export this page using these formats Digital Object Identifier - DOI